Reports Reuters,
Researchers have developed a new way to make embryonic-like stem cells by soaking them in genetically engineered proteins, a new step toward using ordinary cells to treat disease.
An international team led by the Scripps Research Institute in California said on Thursday it is the safest method yet found to transform ordinary skin cells into what are called induced pluripotent stem cells, or iPS cells.
They reported their finding, made using mouse cells, in the journal Cell Stem Cell.
Yet another reason why promising iSPC research is making ESCR (embryonic stem cell research) redundant.
